Aspen Aerogels Q1 revenue $78.7M, net loss $301.2M on $286.6M impairment

ASPEN AEROGELS INC

2025-Q1 EPS reported -$3.67 revenue$78,723,000

Total revenue $78.7M vs $94.5M in Q1 2024; operating cash flow $5.6M.
Net loss of $301.2M includes $286.6M impairment from demobilizing Statesboro, GA plant.
Adjusted net loss $4.8M; adjusted EBITDA $4.9M vs $12.9M a year ago.
GAAP EPS loss $3.67; adjusted EPS loss $0.06.
New PyroThin award with leading American OEM for next-gen prismatic LFP platform.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.